TD Cowen raises Charles River Labs stock price target on earnings outlook
Covered in this story
What has happened since
- Charles River Laboratories is down 1.4% since this was published, 3 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
TD Cowen’s $388 target on $CRL is on the record and being tracked to Nov 2027 (12-month default), scored on the close that day.
TD Cowen’s track record →Analyst targets on Charles River Laboratories
- Jefferies: at $295 · target $340 by Sep 2027 · Buy via Investing.com UK
- JPMorgan: at $266 · target $310 by Aug 2027 · Overweight via Investing.com
- Evercore ISI: at $261 · target $300 by Aug 2027 · Outperform via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CRL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Charles River Laboratories →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.